Literature DB >> 19940480

Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.

Leticia Gutiérrez-Galve1, Manja Lehmann, Nicola Z Hobbs, Matthew J Clarkson, Gerard R Ridgway, Sebastian Crutch, Sebastien Ourselin, Jonathan M Schott, Nick C Fox, Josephine Barnes.   

Abstract

BACKGROUND: Possession of one or more apolipoprotein E (APOE) epsilon4 alleles may influence the distribution of atrophy and clinical phenotype. We aimed to assess the influence of APOE genotype on cortical thickness and regional brain volumes in AD (Alzheimer's disease).
METHODS: We included 38 patients (9 epsilon4 non-carriers, 23 epsilon4 heterozygotes, 6 epsilon4 homozygotes) and 23 controls. Each subject had 2 magnetic resonance imaging (MRI) scans and a neuropsychological battery. Cortical thickness and isthmus cingulate volume were measured using FreeSurfer; the volumes of the hippocampus, whole brain, and lateral ventricles were calculated using manual and semi-automated volumetry.
RESULTS: Compared with controls, cortical thickness was significantly lower: in the bilateral temporal, posterior parietal and occipital regions in non-carriers, in the medial temporal and left parietal regions in heterozygotes, and in the medial temporal lobe in homozygotes. Comparisons between AD subgroups did not show significant differences. A trend for larger brain and isthmus cingulate volumes and smaller hippocampal and ventricular volumes with increasing epsilon4 dose were seen. These differences were supported by neuropsychological profiles.
CONCLUSION: These results suggest that APOE genotype may influence the topography of regional atrophy and cortical thinning in AD. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940480     DOI: 10.1159/000258100

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  13 in total

1.  Adaptive testing for multiple traits in a proportional odds model with applications to detect SNP-brain network associations.

Authors:  Junghi Kim; Wei Pan
Journal:  Genet Epidemiol       Date:  2017-02-13       Impact factor: 2.135

2.  Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.

Authors:  Irene Sintini; Jonathan Graff-Radford; Matthew L Senjem; Christopher G Schwarz; Mary M Machulda; Peter R Martin; David T Jones; Bradley F Boeve; David S Knopman; Kejal Kantarci; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

Review 3.  Current status and future perspectives of magnetic resonance high-field imaging: a summary.

Authors:  Vivek Prabhakaran; Veena A Nair; Benjamin P Austin; Christian La; Thomas A Gallagher; Yijing Wu; Donald G McLaren; Guofan Xu; Patrick Turski; Howard Rowley
Journal:  Neuroimaging Clin N Am       Date:  2012-05       Impact factor: 2.264

4.  APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease.

Authors:  Yu-Ling Chang; Christine Fennema-Notestine; Dominic Holland; Linda K McEvoy; Nikki H Stricker; David P Salmon; Anders M Dale; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2013-07-27       Impact factor: 21.566

5.  Neuroimaging PheWAS (Phenome-Wide Association Study): A Free Cloud-Computing Platform for Big-Data, Brain-Wide Imaging Association Studies.

Authors:  Lu Zhao; Ishaan Batta; William Matloff; Caroline O'Driscoll; Samuel Hobel; Arthur W Toga
Journal:  Neuroinformatics       Date:  2021-04

6.  MIRIAD--Public release of a multiple time point Alzheimer's MR imaging dataset.

Authors:  Ian B Malone; David Cash; Gerard R Ridgway; David G MacManus; Sebastien Ourselin; Nick C Fox; Jonathan M Schott
Journal:  Neuroimage       Date:  2012-12-28       Impact factor: 6.556

7.  Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features.

Authors:  Anandhi Iyappan; Erfan Younesi; Alberto Redolfi; Henri Vrooman; Shashank Khanna; Giovanni B Frisoni; Martin Hofmann-Apitius
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study.

Authors:  David M Cash; Gerard R Ridgway; Yuying Liang; Natalie S Ryan; Kirsi M Kinnunen; Thomas Yeatman; Ian B Malone; Tammie L S Benzinger; Clifford R Jack; Paul M Thompson; Bernardino F Ghetti; Andrew J Saykin; Colin L Masters; John M Ringman; Stephen P Salloway; Peter R Schofield; Reisa A Sperling; Nigel J Cairns; Daniel S Marcus; Chengjie Xiong; Randall J Bateman; John C Morris; Martin N Rossor; Sébastien Ourselin; Nick C Fox
Journal:  Neurology       Date:  2013-09-18       Impact factor: 9.910

9.  A comparison of FreeSurfer-generated data with and without manual intervention.

Authors:  Christopher S McCarthy; Avinash Ramprashad; Carlie Thompson; Jo-Anna Botti; Ioana L Coman; Wendy R Kates
Journal:  Front Neurosci       Date:  2015-10-21       Impact factor: 4.677

10.  Seed Location Impacts Whole-Brain Structural Network Comparisons between Healthy Elderly and Individuals with Alzheimer's Disease.

Authors:  Lauren Zajac; Bang-Bon Koo; Corinna M Bauer; Ron Killiany
Journal:  Brain Sci       Date:  2017-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.